Results for tag: "Temozolomide"

Temozolomide is an alkylating agent used in the treatment of certain types of cancer, most notably glioblastoma multiforme. It is a prodrug, which is converted in the body to its active form, 5-(3-methyltriazen-1-yl)imidazole-4-carboxamide (MTIC). Temozolomide is used in combination with radiation therapy to treat newly diagnosed glioblastoma multiforme, and as a single agent to treat recurrent glioblastoma multiforme. It is also used to treat anaplastic astrocytoma, a type of brain tumor. Temozolomide is a generic drug, and is available in many countries. It is marketed by several companies, including Merck, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more